Anacura
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Anacura - overview
Established
1985
Location
-, -, Belgium
Primary Industry
Pharmaceuticals
About
Anacura, based in Belgium, operates as an independent analytical laboratory specializing in healthcare and drug development, providing high-quality analytical solutions to healthcare professionals and patients. Founded in 1985, Anacura is an independent analytical laboratory serving the healthcare and drug development sectors. The company has not undergone any significant pivots or changes in its business strategy. Anacura is headquartered in Belgium and focuses on providing analytical services to pharmaceutical and biotech companies, healthcare providers, and researchers.
The founder's history and additional details regarding funding rounds are not available. Anacura provides a wide range of analytical services through its divisions, AnaBioTec and OHMX. bio. AnaBioTec focuses on Chemistry, Manufacturing, and Controls (CMC) activities, which support drug development for Small Molecules, Biologics, and Cell & Gene Therapy throughout their preclinical, clinical, and commercial phases.
OHMX. bio specializes in advanced genomics and bioinformatics, offering insights in transcriptomics and proteomics. The company has been committed to delivering scientifically validated laboratory medicine for over 40 years, primarily serving clients in European markets. Anacura generates revenue through B2B transactions with pharmaceutical and biotech clients.
The firm engages in partnerships and project-based collaborations, where clients pay for specific analytical services based on their needs during various stages of drug development. Revenue is derived from service agreements that include fixed-fee contracts for comprehensive projects or per-sample pricing for specific analyses. The analytical services provided by AnaBioTec and OHMX. bio allow clients to select tailored solutions that meet their specific research and development requirements.
Details regarding Anacura's future growth plans, including new products or market expansion, are currently not available. Specific strategies and how recent funding will be utilized to support these initiatives have not been disclosed.
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Biopharmaceuticals, Pharmaceuticals
Website
www.anacura.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.